Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TQL Block vs PCI for Hip Arthroscopy
NCT04353414Phase 4Completed
- Sponsor
- NYU Langone Health
- Start
- Aug 2020
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by NYU Langone Health. Primary endpoints: Visual Analogue Scale Pain Score at 1 day and McGill Pain Questionnaire Score at 1 day. Started Aug 2020; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04353414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04353414.